Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
    Optimizing HRRm Testing and Workflow Integration in mCSPC
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement, Research Oncology Canada
    Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across Canada
    Release Date:
    Partner: Colorectal Cancer Canada (CCC)
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement, Research Oncology Canada
    Optimizing Disease Management to Improve Alopecia Areata Quality of Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) Therapy
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Oncology Canada
    2026 Headache Medicine Fellowship - US
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Internal Medicine USA
    Advances in Migraine Management
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Real-World Evidence of SUL-DUR on Special Populations with CRAB Infection
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local Level
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator Therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Use of AI to Improve Speed/Precision of Treatment Selection & Clinical Management for Patients w/ Invasive Mold Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Australia, China, France, Germany, Italy, Korea, Spain, Taiwan, United Kingdom
    Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patients
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Spain
    Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Efforts to Improve Quality of Migraine Care
    Release Date:
    Partner: The Japanese Headache Society
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Internal Medicine Japan
    Enhancing HCP Education in Adult Vaccination against Respiratory Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland
    Migraine and Women’s Health
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement, Research Internal Medicine USA
    Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare Professionals
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Prostate Cancer: Best Practices for Combining Targeted Therapies in mPC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Transthyretin Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Optimizing Adult Vaccination Ecosystem in India
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Vaccines India
    Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology Spain
    Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific Antibodies
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
    Enhancing HCP Education in Maternal Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Saudi Arabia
    Diagnosis and Treatment of Cancer Cachexia
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic Diseases
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2026 Hemophilia Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi Arabia
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Saudi Arabia
    Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing Equity
    Release Date:
    Review Process: Expert Review Panel
    Education Inflammation & Immunology Australia
    Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in Türkiye
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Turkey
    Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in Türkiye
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Turkey
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Invasive Fungal Infections (Emerging market countries listed in Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Accelerate Promotion and Dissemination of Appropriate Atopic Dermatitis Diagnosis, Treatment, and Management Guidance
    Release Date:
    Partner: Japanese Dermatological Association
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Japan
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Pediatric Endocrinology Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    Growth Hormone Research- United States
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease USA
    Treatment of acute SARS-CoV-2 infection and management of post-COVID conditions in outpatient settings (European countries)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Topical Hemostasis in Hospital Outpatient and Ambulatory Surgery
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Education for Improving Appropriate Diagnosis and Treatment for Venous Thromboembolism
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Establishment of System for Early Detection of Atrial Fibrillation and Prevention of Cardiogenic Embolism
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine Japan
    Atopic Dermatitis and Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada
    Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care Professionals
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Bladder Cancer Canada-EMD Serono-Pfizer Quality Improvement Request for Proposals
    Release Date:
    Partner: Bladder Cancer Canada, EMD Serono
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    Addressing Healthcare Disparities in the Recognition, Early Diagnosis and Treatment of Primary Immunodeficiencies
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Knowledge Gaps in the Prevention of COVID-19 in Europe
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
    Hemophilia: Improving Knowledge of Novel Hemophilia Therapies Amongst Multidisciplinary Teams
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Optimizing Androgen Deprivation Therapy (ADT) in Advanced Prostate Cancer
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Oncology USA
    Quality of Care Initiative to Improve the Treatment of Advanced or Metastatic Bladder Cancer Patients
    Release Date:
    Partner: NCCN, EMD Serono
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Educational Projects for Healthcare Professionals to Promote Cancer Patient Support
    Release Date:
    Partner: Japan Society of Clinical Oncology
    Review Process: Expert Review Panel
    Education Oncology Japan
    Latin America Needs Assessment of Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Menopause and Mental Health
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Efforts to Promote an Environmental Improvement for Cancer Genomic Medicine
    Release Date:
    Partner: Japan Society of Clinical Oncology
    Review Process: Expert Review Panel
    Education Oncology Japan
    Understanding of Biosimilars and Shared Decision Making including Financial Burden in Cancer Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Review and analysis of retrospective, local source, serotype distribution for invasive pneumococcal disease
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Addressing Diagnostic Challenges for Non-Alcoholic Steatohepatitis (NASH)
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Rheumatology Education Healthcare Disparities
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Promotion of the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Improving Knowledge and Capability to Communicate Information on the Latest Hemophilia Treatments
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Equity in Access to Cancer Cachexia Clinical Trials
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Internal Medicine All
    Infectious Disease Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Hospital India
    Inflammatory Bowel Disease (Europe, Canada, Australia, New Zealand, Japan, Israel and Turkey)
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology All
    Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Partner: Mayo Clinic
    Review Process: Expert Review Panel
    Translation: Arabic (link)
    Translation: French (link)
    Translation: Mandarin (link)
    Translation: Spanish (link)
    Quality Improvement Rare Disease All
    2022 Growth Hormone Research
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Meta-analysis of COVID-19 Vaccine Hesitancy Behavioral & Social Science Research
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines USA
    New & Emerging Therapies for Atopic Dermatitis for Dermatologists, Allergists, and Advanced Practice Providers
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Addressing the Needs of Patients with Mental Health Issues and Inflammatory Bowel Diseases
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada
    Improving the Care of Patients with Disorders of Impaired Growth
    Release Date:
    Partner: ICOSEP
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease All
    Promote Understanding of Respiratory Infections (Streptococcus pneumoniae, Influenza virus, RSV, GBS, SARS-Cov-2)
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Increasing the Awareness of the Importance of Vaccination during Pregnancy
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Understanding Alopecia Areata for Dermatologists, Pediatric Dermatologists, and Advanced Practice Providers
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Capacity Building for Antimicrobial Stewardship
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Japan
    Implementation of Systemic Treatment Approaches in Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Oncology Capacity Building in Sub-Saharan Africa (including CABO VERDE and ESWATINI)
    Release Date:
    Partner: Mayo Clinic Global Bridges Oncology
    Review Process: Expert Review Panel
    Translation: French (link)
    Translation:(link)
    Quality Improvement Oncology Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, The Democratic Republic, Cote D'ivoire, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, Sudan, Tanzania, United Republic of, Togo, Uganda, Zambia, Zimbabwe
    Improving Clinical Management for Patients with Breast Cancer in China
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology China
    NSCLC Cancer Precision Diagnosis and Treatment
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology China
    Advancing Management and Care in Atrial Fibrillation and Venous Thromboembolism
    Release Date:
    Partner: BMS
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Addressing Knowledge Gaps in Aplastic Anemia
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Knowledge Gaps in Treatment of Acute COVID-19 and Management of Post-COVID Conditions in Outpatient Settings
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Digital Education to Address Patients with COVID-19 and High Risk of Complications
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All